BERLIN—Pfizer Inc. partner BioNTech and U.S. drugmaker Moderna Inc. both applied for their coronavirus vaccines to be approved in the European Union, the EU’s chief medicines regulator said Tuesday, with officials expected to make a decision on at least one of the vaccines by the end of the month.
The announcement brings hope that the EU will soon be able to start vaccinating its 448 million people against a disease that has done some of its earliest and worst damage on the continent.
The…
This post first appeared on wsj.com
